1 Data
were available for 1 238 188 patients, covering 64 Natio
2 Individual patient data
were available for 10 553 patients.
3 air pollution exposure from previous studies
were available for 10,000 children.
4 rticipated, complete, good-quality data sets
were available for 100: 48 currently depressed older adu
5 strategy (Q1 + Q2 + implemented management)
was available for 101 of 161 patients (63%).
6 Home-based vaccination cards
were available for 1210 of 1934 children (63%) surveyed.
7 on on the apolipoprotein E (Apo-E) phenotype
was available for 1259 men.
8 Week 12 outcome data
were available for 132 patients who initiated with mesal
9 Primary outcome data
were available for 134 (72%) patients at 12 months.
10 Genital and anal specimens
were available for 1348 MSW participants, and HPV genoty
11 HbA1c data at follow-up
were available for 146 people in the intervention group
12 Complete data on the primary outcome
were available for 1497 infants (95.6%).
13 Data on BMI
were available for 15 237 participants.
14 IQ scores
were available for 150 patients (60 had received XRT, 90
15 Primary outcome data
was available for 152 control practices (dentists = 438)
16 Psychopathology and imaging data
were available for 1538 youths.
17 at age of 8 years, and potential confounders
were available for 1608 participants of the PIAMA birth
18 amples and biennial follow-up questionnaires
were available for 164 BRCA1/2-mutation carriers with no
19 Data
were available for 18 articles to be included in the met
20 Gradable fundus photographs
were available for 1809 participants who attended both b
21 randomized patients, baseline health status
was available for 1833 individuals (950 TAVR, 883 SAVR)
22 Laboratory-confirmed HIV status
was available for 19 330 respondents in Zambia and 18 00
23 Day 35 MRD status
was available for 191 patients.
24 CYP2C19 genotype data
was available for 2 423 patients and the final sample co
25 s enrolled, RT-PCR and serology test results
were available for 2,023, including 1,087 children below
26 Data
were available for 2,520 patients, and the most common c
27 2-72] years), complete 1-year follow-up data
were available for 2164 (98.5%).
28 After crossover, data
were available for 22 itMSC patients.
29 Complete data
were available for 225 children; there were 87 cases of
30 lfur application and relevant covariate data
were available for 237 and 205 children for whom we had
31 Outcome data
were available for 248 plans (68% of plans operating pri
32 Results: Sequencing data
were available for 254 (56%) of the NeoALTTO participant
33 Sequencing data
were available for 254 (56%) of the NeoALTTO participant
34 Urine specimens
were available for 260 women with 85.4% from the America
35 Neuroimaging data
were available for 274 participants.
36 l risk factor measurements and location data
were available for 28 887 (96%).
37 The data of both US and CAP
were available for 289 children.
38 Load
was available for 290 of 291 cases with pneumococcal PCR
39 In total, exposure data
were available for 296 subjects, 188 of whom had complet
40 ilable for 3,637 (90%); hospital information
was available for 3,531 (87%).
41 4,058 unique individual plans, network data
were available for 3,637 (90%); hospital information was
42 Follow-up
was available for 30 (75%) patients with crystalline LCP
43 Of the 503 study participants, MSI results
were available for 303 patients (283 with microsatellite
44 As of Feb 28, 2015, follow-up information
was available for 3083 patients for overall survival and
45 s; 17949 women [54.3%]), follow-up at 1 year
was available for 31229 (94.5%).
46 Complete data
were available for 3152 participants (aged 15 years; 53%
47 Clinical follow-up
was available for 32 women; 5 died of cardiovascular com
48 Complete (18)F-FDG PET data
were available for 32 of 45 patients.
49 Complete records
were available for 323 women; 54 women met criteria for
50 Self-reported health and lifestyle habits
were available for 34,202 participants in the Swedish Tw
51 Results Biomarker data
were available for 340 patients.
52 Full data
were available for 3482 participants (48% men; mean age
53 Neurodevelopmental outcome data
were available for 365 (81%) at a mean age of 23.6 month
54 outine growth data from birth to age 2 years
were available for 3659 children between 1976 and 2012.
55 f corneal abnormalities, CH and CRF readings
were available for 382 Indian persons.
56 High-confidence TOPKAT LOAEL estimates
were available for 389 of 1026 hydraulic fracturing-rela
57 vived to 18- to 22-month follow-up, and data
were available for 3892 of 4284 infants (90.8%).
58 -year data for this extended follow-up trial
were available for 391 patients (78.2%) and information
59 RDT results
were available for 40 of these surveys including 40 261
60 Plasma samples
were available for 40 patients after disease progression
61 In the combined cohort, data
were available for 40 patients at baseline and 38 patien
62 Patient information
was available for 41 of the isolates.
63 Five-year echocardiogram data
were available for 424 patients after TAVR and 49 after
64 Data on the primary outcome
were available for 4274 of 4458 infants (96%) born at th
65 Outcomes data
were available for 435 of the 483 women (90.1%).
66 Results Sufficient data
were available for 4431 nodules (4315 benign nodules and
67 Complete information
was available for 456,711 (77.7%) of 587,710 women who h
68 91 patients (78.2%) and information on death
was available for 459 patients (91.8%).
69 eceived eliglustat in the ENCORE trial; data
are available for 46 patients who received eliglustat fo
70 Genome-wide association study data
were available for 4609 individuals with ADHD, 9650 indi
71 of maternal concern about child weight.Data
were available for 4689 mother-child dyads participating
72 Information
was available for 47027 of 47124 births (99.8%) at surve
73 performance tests at the 4-y re-examinations
were available for 480 men.
74 aging at baseline, longitudinal imaging data
were available for 501 persons (mean age, 69.9 years; ag
75 Primary outcome data
were available for 525 (86%) participants.
76 Data to estimate NSP coverage
were available for 57 countries, and for 60 countries to
77 Examination Survey (NHANES) III (1988-1992)
were available for 6032 individuals aged 50 years old or
78 At long-term follow-up (results of which
were available for 63% of the patients), the most common
79 ere eligible; however, AL data for both eyes
were available for 64 patients at baseline and 69 patien
80 formation regarding post-Fontan intervention
was available for 70%.
81 Results from 2 IS samples
were available for 719 children (79.4%).
82 Data
were available for 75 countries, representing 2.106 bill
83 The primary outcome
was available for 7677 (96%) participants.
84 ort respiratory muscle strength measurements
were available for 78 patients with ALS.
85 sts for Zika virus and brain imaging results
were available for 79 (87%) cases; within these cases, t
86 functional magnetic resonance imaging scans
were available for 82 subjects.
87 Postintervention data
were available for 8271 women and 5371 children younger
88 otid artery intima-media thickness (CCA-IMT)
were available for 846 men.
89 6 months, data for the Oxford Shoulder Score
were available for 90 patients assigned to decompression
90 ed case-control study, cognitive test scores
were available for 924 male cases and 19,530 male contro
91 Clinical data
were available for 93 female %DHR(+) values were 46% (me
92 RSs
were available for 979 patients.
93 2 children in the birth cohort, genetic data
were available for 9912 adolescents.
94 Data
were available for 992 (99.2%) trial participants (496 i
95 nd oral slope factors (OSFs) for cancer-that
are available for a list of 1173 chemicals that the Unit
96 eous disease and specific therapies have not
been available for a long time.
97 s freely available for academic research and
is available for a fee for commercial use.
98 ultiple time points, and once a segmentation
is available for a time sequence cells can be analyzed t
99 Cord blood and age-14 serum
were available for a subgroup (n = 40) and were also ana
100 ure has inherent complications and might not
be available for all patients.
101 structured framework adapted from oncology)
is available for all biomarkers, but their clinical vali
102 This package
is available for all commonly used platforms.
103 The minfi package version 1.19.12 or higher
is available for all platforms from the Bioconductor pro
104 ealth grants, and registered clinical trials
were available for all academic cardiologists.
105 driver and selected nondriver myeloid genes
were available for all patients.
106 ecause no pharmacokinetic data in recipients
were available for all products.
107 ohort and, after quality control, 228 exomes
were available for analyses.
108 ls in blood), only a limited number of cells
are available for analysis.
109 ct that even if only one persistence diagram
is available for analysis-the typical case for big data
110 One induced sputum sample
was available for analysis from 3772 (89.1%) of 4232 sus
111 The remaining 384 patients
were available for analysis (222 men [57.8%]; 162 women
112 In group 1, 91 serum samples
were available for analysis 1 month after booster immuni
113 pants (mean [SD] age, 31.3 [5.6] years), 166
were available for analysis at 24 months (retention, 80.
114 One hundred ninety-seven patients
were available for analysis because 3 patients withdrew
115 180-day follow-up data
were available for analysis from 246 of 249 participants
116 Three hundred eighty-six patients
were available for analysis in the intention-to-treat an
117 Data from 27 patients (82%)
were available for analysis in this study.
118 data from 597, 587, and 439 women or babies
were available for analysis of obstetric, neonatal, and
119 both standard-dose and synthetic mammograms
were available for analysis were retrospectively analyze
120 with Parkinson's disease from the PPMI study
were available for analysis, and 317 patients with Parki
121 edish surgical departments, and 112 patients
were available for analysis.
122 interquartile range (IQR), 28.0-42.0 years])
were available for analysis.
123 es in which data for fewer than ten children
were available for analysis.
124 61 genomic data from Kilifi, eastern Kenya,
were available for analysis.
125 Reliable protocols have long
been available for antibody staining of Drosophila whole
126 le for correlation analysis, and 12 patients
were available for assessment of tumor overlap.
127 obank, in whom 77 of the 100 suggestive SNVs
were available for association analysis with systolic BP
128 Several hydrolyzed cow's milk (CM) formulas
are available for avoidance of allergic reactions in CM-
129 of now, no sensitive and inexpensive method
is available for beta-A detection under physiological an
130 Proven and cost-effective interventions
are available for both these common cancers, yet for so
131 Although Gene Ontology (GO)
is available for Caenorhabditis elegans, it does not inc
132 Few methods
are available for calculating heritability for traits de
133 neuroendocrine tumors, and only limited data
are available for cancer types with lower SSTR expressio
134 tional agreed standard outcomes (ICHOM) sets
are available for cataract surgery (10 metrics) and macu
135 ual drug with pleiotropic beneficial effects
is available for CF.
136 liver disease, and hepatitis C, but no data
are available for CHB.
137 s, compositions, and constituent elements to
be available for chemical and energy transformations thr
138 PNIF normative data
are available for children, adults and elderly subjects,
139 e is expected to be safe and immunogenic and
is available for clinical development.
140 expected to be well tolerated in humans and
is available for clinical evaluation.IMPORTANCE EBOV hem
141 repertoire of promising therapeutic options
is available for clinical evaluation; however, the numbe
142 A model
is available for comparing kinetic parameters and AC of
143 e that can be used even when few individuals
are available for comparison or when genomes are sequenc
144 ries quiescent, stored in a latent form that
is available for context-relevant activation.
145 Seventeen patients
were available for correlation analysis, and 12 patients
146 ls of the volumetric CT dose index (CTDIvol)
are available for dedicated CT procedures on selected bo
147 Easy-to-use APIs
are available for developers to reuse and extend Web3DMo
148 Even though a variety of software packages
is available for different aspects of the bioinformatics
149 E EBV causes human lymphomas, but few models
are available for dissecting how EBV causes lymphomas in
150 each with distinct strengths and weaknesses,
are available for distance-matrix based analysis of larg
151 Many high-quality genomes
are available for dixenous (two hosts) trypanosomatid sp
152 le HMMs, hit lists and other underlying data
are available for download.
153 urce computational workflows and models will
be available for download and application to local data.
154 code, implemented in C ++ on a linux system,
is available for download at ftp://ftp.ncbi.nlm.nih.gov/
155 Our code and data
is available for download from github.com/medvedevgroup/
156 od has been implemented as an R package, and
is available for download through Bitbucket.
157 ANARCI
is available for download under GPLv3 license at opig.st
158 However, only a small number of CCS values
are available for drugs, which limits the use of CCS as
159 No licensed vaccines
are available for either disease, but vaccines for both
160 However, relatively few data
are available for evaluation of zoonotic transmission.
161 elective synthesis of alpha-secondary amines
are available (for example, from additions to protected/
162 e dough stage that insufficient thiol groups
were available for forming dough layer interconnections
163 The package has a web-interface and it
is available for free for academic use.
164 The results of this study
are available for further examination via NeuroVault.
165 entangled state with increased fidelity that
is available for further use.
166 Countless options
are available for fusing magnetically active species wit
167 es developed by various computing techniques
are available for gene prediction.
168 ning to physical linkage or genomic position
are available for genetic markers, estimates of recombin
169 and controls, analyzable laboratory results
were available for &
gt;/=96% of core specimens collected.
170 Similar interpretations
are available for H3N2, but right-censoring of titers ma
171 e acceptable, evidence based guidelines must
be available for healthcare professionals and cleaning m
172 No once-daily single-tablet regimen
is available for HIV-infected children under 12 years.
173 The 10-year outcome data
were available for ILA (n = 561) and mortality (n = 1,22
174 High resolution structures
are available for individual receptors dimers, but less
175 A specific therapeutic intervention
is available for individuals testing positive for influe
176 Many software packages
are available for inferring local ancestry in admixed in
177 lts were imprecise and relatively few trials
were available for interventions other than low-frequenc
178 porters, but limited structure-activity data
are available for its analogs.
179 imaging (MRI), and computed tomography (CT)
are available for its evaluation.
180 eceptors have been reported, no such ligands
are available for KARs.
181 SNP)-SNP interactions, and no practical tool
is available for large-scale investigations of the inter
182 GeNN
is available for Linux, Mac OS X and Windows platforms.
183 dence regarding cardiovascular safety, which
is available for lixisenatide, alogliptin, saxagliptin,
184 dity and mortality worldwide, but scant data
are available for long-term outcomes in individuals outs
185 Although limited data
were available for low-income and middle-income countrie
186 disorders, to date, few effective treatments
are available for lymphatic diseases.
187 Although a plethora of tools
are available for making pathogenicity predictions over
188 Several interventions
are available for management of obsessive-compulsive dis
189 -reported outcomes in clinical research, few
are available for measuring upper limb function post-str
190 No completely accurate method
is available for measuring CO in all patients.
191 h performance comparable to reference assays
are available for molecular and serological diagnosis of
192 Phytomonas, but only fragmentary information
is available for monoxenous (single-host) trypanosomatid
193 .2] years; 80.6% white), mortality follow-up
was available for more than 98%.
194 Data
were available for more than 550 000 individuals and 51
195 Since no actual physicochemical data
is available for most derivatized compounds, the respons
196 Paired tumor and plasma samples
were available for most patients (24 of 30).
197 No algorithm or methodology
is available for multi-factor analysis of differential c
198 nt intravenous iron formulations, which have
been available for nearly a decade, seem to replenish ir
199 e high Fe/NOM ratio, sufficient or excess Fe
was available for NOM removal, and coagulation proceeded
200 hs from cirrhosis in the West, but few tools
are available for noninvasive diagnosis of alcoholic liv
201 No definitive cure
is available for OI and to develop novel drug therapies,
202 us recombination in embryonic stem cells and
are available for only 25% of all mouse genes.
203 iversity, although comprehensive assessments
are available for only 46% of species.
204 es and dynamics of polyubiquitin signals but
are available for only five out of eight linkage types.
205 No data on large study populations
are available for other phenols with possible endocrine-
206 sults Of patients, 82 were identified and 78
were available for outcome analysis; 32% received T-DM1
207 TB for a century, while drug treatments have
been available for over 70 years; despite this, TB remai
208 Methods to this end have
been available for over a decade and, with a critical ma
209 Several therapeutic alternatives
are available for palliative treatment.
210 Few treatment options
are available for patients with advanced and recurring e
211 ective first-line systemic treatment options
are available for patients with advanced BRAF-mutated me
212 In addition, new treatment options
are available for patients with advanced systemic mastoc
213 Purpose No effective salvage treatments
are available for patients with advanced/recurrent thymo
214 Purpose Few therapeutic options
are available for patients with Philadelphia chromosome-
215 eatments with a distinct mechanism of action
are available for patients with platinum-refractory adva
216 ase, and we offer recommendations, when data
are available, for patients with other clinical indicati
217 vertical clinical attachment level [CAL-V])
were available for patients at baseline and 12 months af
218 tense investigation, no interdictive therapy
is available for PD.
219 iffusion from the gastric fluid, but no data
are available for pepsin diffusion.
220 Command line tools
are available for performing integrated error correction
221 Unless more selective microglial markers
are available for PET imaging, quantification of cytokin
222 Currently no licensed treatment
is available for PIV infection.
223 Whereas a vaccine
is available for prevention of shingles, its efficacy de
224 Prophylactic HPV vaccine
is available for primary prevention.
225 patients received the intended treatment and
were available for primary outcome measurement.
226 ingly, routine sequencing technologies-which
are available for proteins and DNA and have revolutionis
227 ion regardless of how many sequence homologs
are available for proteins in question.
228 As of August 2016, 238 cell lines
are available for purchase.
229 Only a few existing techniques
are available for quantification of structural changes a
230 Noncomparative and indirect evidence
was available for questions about stopping versus contin
231 mPFC areas were registered to MNI space and
are available for regional analysis of functional magnet
232 Currently, two models
are available for researchers to determine the oligomeri
233 Among enrolled patients whose medical charts
were available for review post-discharge, 61 (27%) were
234 Four large database studies
were available for review, including 2 published after t
235 y (CT) and a CT angiography (CTA) at arrival
were available for review.
236 lity in clinical studies, no equivalent tool
is available for rodent animal samples.
237 Comparable occupation data
were available for Scotland in 1991, allowing assessment
238 Although programs
are available for sequence-based prediction of lipid acc
239 For remote programmatic access, API's
are available for several programming languages.
240 ests that reduced amounts of CER3 transcript
are available for siRNA synthesis, possibly because CER3
241 Activators
are available for Sirt1 and exploit its unique N-terminu
242 t amounts of sequencing, more reads per site
are available for SNP calling.
243 g pollution levels, very limited information
is available for South Asia.
244 The 5-year outcome data
were available for spirometry (n = 697), cough (n = 722)
245 ure that appropriate amounts of each isoform
are available for such disparate gene expression process
246 However, scant guidance
is available for surgeons seeking to develop peer-coachi
247 here time is a factor and only small volumes
are available for testing.
248 Tissue
was available for testing in 43 patients, and 32 (74%) h
249 ionization methods in mass spectrometry (MS)
are available for the analysis of analytes with differen
250 Although several computational approaches
are available for the annotation of spectra obtained fro
251 date no satisfactory technological solutions
are available for the automated, miniaturized and integr
252 No evidence-based guidelines
are available for the definitive diagnosis or directed t
253 reds of genetically characterized cell lines
are available for the discovery of genotype-specific can
254 Few data
are available for the efficacy of "triple therapy" with
255 Limited data
are available for the efficacy of triple therapy with tw
256 Limited data
are available for the epidemiology and outcome of colore
257 Although structures
are available for the nucleocapsid protein in complex wi
258 , only inactivated influenza vaccines (IIVs)
are available for the prevention of CIV in dogs.
259 A wide range of experimental systems
are available for the study of spontaneous or environmen
260 of agents with distinct mechanisms of action
are available for the treatment of patients with multipl
261 However, surprisingly, no data
are available for the viscosity of supercooled water und
262 ecular structure of the detected compound to
be available for the algorithm, the identification of no
263 ic traits, whole-genome marker profiles will
be available for the entire set of breeding lines, enabl
264 No effective pharmacologic treatments have
been available for the hyperphagia and obesity that char
265 Methods have
been available for the last ten years to perform the inf
266 As yet, no open source software
is available for the automatic gating of two channel ddP
267 To date, no specific test
is available for the diagnosis of the whole spectrum of
268 No tool
is available for the early assessment of response to ant
269 arvation response (P0), very few information
is available for the effect of excess phosphate Pi on pl
270 No treatment
is available for the neurological manifestations of the
271 carbapenemases (KPC), no specific inhibitor
is available for the phenotypic detection of OXA-48.
272 es but few are used to date, because no tool
is available for the systematic evaluation of restrictio
273 Level I evidence also
was available for the role of macular grid laser photoco
274 5 receiving placebo) completed the study and
were available for the primary analysis.
275 Data pertaining to 1,250,449 admissions
were available for the study period.
276 s of the data in each report, and where data
were available for the years before and after a ban, we
277 Many strategies
are available for their chemical macrocyclization, howev
278 elatively few commercially produced reagents
are available for their study.
279 lishes limits to the microRNA machinery that
is available for therapeutic siRNAs and suggests new par
280 Currently, no disease-modifying treatments
are available for these disorders.
281 Unfortunately, little structural information
is available for these complexes; indeed, for the highly
282 ificant loci, although no replication sample
was available for these.
283 a caused by mutations in NOTCH3 No therapies
are available for this condition.
284 Online supplemental material
is available for this article.
285 ISRCTN10888758 Online supplemental material
is available for this article.
286 ISRCTN10888758 Online supplemental material
is available for this article.
287 Online supplemental material
is available for this article.
288 (c)) RSNA, 2017 Online supplemental material
is available for this article.
289 t glucose-responsive insulin-producing cells
are available for transplantation.
290 ng domestic corneas in which fresher tissues
were available for transplantation.
291 Several pharmacological treatment options
are available for type 2 diabetes; however, many patient
292 eralized freeze-dried bone allografts (FDBA)
are available for use in alveolar ridge preservation aft
293 The paradigm
is available for use in 3-D and in 2-D (e.g., for the MR
294 and 58 samples from a total of 172 patients
were available for validation of creatinine, TaC and CsA
295 tients with Parkinson's disease from LABS-PD
were available for validation.
296 amine in wastewater, but limited information
is available for viruses, especially ones of mammalian o
297 he intra-motif dependencies, but fewer tools
are available for visualization.
298 n cross-platform C ++ and binary executables
are available for Windows, macOS and Linux.
299 ugh preclinical and clinical trials and have
been available - for years in some cases - before being
300 hough international reference materials have
been available for years, the standardization of immunoa